Elizabeth Holmes and Theranos: The Patients Were the Real Victims
You Can See Everything': A24 Released Elizabeth Holmes Documentary yesterday October 16 From Lance Oppenheim, Nathan Fielder
Follow the data, not the funding.
Independent reporting on medicine, healthcare, and the industry behind it, with no pharmaceutical backing.
EU Regulators Back Daraxonrasib, the Pill That Nearly Doubled Survival in Advanced Pancreatic Cancer
Europe's medicines committee has recommended approval of daraxonrasib, an oral RAS-targeting drug for metastatic pancreatic cancer. In a 500-patient phase 3 trial, it extended median survival from 6.7 to 13.2 months compared with chemotherapy. Here is what the data show and what remains uncertain.